UA110226C2 - Antibodies to cd38 - Google Patents

Antibodies to cd38

Info

Publication number
UA110226C2
UA110226C2 UAA201308436A UAA201308436A UA110226C2 UA 110226 C2 UA110226 C2 UA 110226C2 UA A201308436 A UAA201308436 A UA A201308436A UA A201308436 A UAA201308436 A UA A201308436A UA 110226 C2 UA110226 C2 UA 110226C2
Authority
UA
Ukraine
Prior art keywords
antibodies
seq
antibody
nucleic acid
producing
Prior art date
Application number
UAA201308436A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Kathleen Ann Elias
Gregory Landes
Shweta Singh
Wouter Korver
Andrew Walling Drake
Mary Haar-Frendscho
Gyorgy Pal Snell
Vinay Bhaskar
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Priority claimed from PCT/US2011/068235 external-priority patent/WO2012092612A1/en
Publication of UA110226C2 publication Critical patent/UA110226C2/en

Links

Abstract

Винахід належить до антитіла проти CD38 людини (SEQ ID NO: 1) та СD38 яванського макака (SEQ ID NO: 2), виділеної нуклеїнової кислоти, клітини-хазяїна, способу одержання зазначеного антитіла та способу лікування за допомогою вказаних антитіл.The invention relates to antibodies against human CD38 (SEQ ID NO: 1) and CD38 cynomolgus macaque (SEQ ID NO: 2), a selected nucleic acid, a host cell, a method for producing said antibody and a method of treatment using said antibodies.

UAA201308436A 2010-12-30 2011-12-30 Antibodies to cd38 UA110226C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428699P 2010-12-30 2010-12-30
PCT/US2011/068235 WO2012092612A1 (en) 2010-12-30 2011-12-30 Anti-cd38 antibodies

Publications (1)

Publication Number Publication Date
UA110226C2 true UA110226C2 (en) 2015-12-10

Family

ID=55171456

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201308436A UA110226C2 (en) 2010-12-30 2011-12-30 Antibodies to cd38

Country Status (2)

Country Link
AR (1) AR123972A2 (en)
UA (1) UA110226C2 (en)

Also Published As

Publication number Publication date
AR123972A2 (en) 2023-02-01

Similar Documents

Publication Publication Date Title
PH12017501114A1 (en) Anti-c5 antibodies and methods of use
EA201591131A1 (en) DNA STRUCTURE ANTIBODY AND METHOD OF THEIR APPLICATION
EA201400875A1 (en) ANTIBODIES TO CD47 AND METHODS OF THEIR APPLICATION
MX348071B (en) Fc variants.
NZ607969A (en) Cd33 binding agents
CY1121742T1 (en) S100A4 ANTIBODIES AND THERAPEUTIC USES THEREOF
MX2022014885A (en) Anti-c5 antibodies and methods of use.
MY166282A (en) Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
UA115439C2 (en) Humanized antibodies that recognize alpha-synuclein
MX349630B (en) Alpha-amylases.
MX2013001845A (en) Antibodies that bind myostatin, compositions and methods.
EA201492101A1 (en) ANTIBODIES AGAINST FCRN
BR112012015255A2 (en) "antibody, pharmaceutical composition, use of an antibody, method of treatment, nucleic acid, expression vector, host cell and method of producing a recombinant antibody"
SG178886A1 (en) Humanized anti-cdcp1 antibodies
UA118354C2 (en) Antibodies
EA201290961A1 (en) METHODS OF APPLICATION OF SOLUBLE CD24 FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
UA113623C2 (en) TISSUE FACTOR FACTOR (TFPI) MONOCLONAL ANTIBODY AGAINST TISSUE FACTOR INHIBITOR
MX359854B (en) Anti-cxcr3 antibodies.
EA201491286A1 (en) METHOD OF TREATING BONE LOSS OF ALVEOLAR PROCESS BY MEANS OF ANTIBODIES TO SCLEROSTIN
WO2011092593A3 (en) Hiv-1 neutralizing antibodies and uses thereof
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
WO2014028668A3 (en) Stem cell enhancing therapeutics
FI20115328A (en) New cutinases, their production and uses
WO2012122334A3 (en) Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
TR201908197T4 (en) New anti-human IL-23 receptor antibody.